{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/migraine/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"86e96919-af81-53dc-805a-36533fa27637","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field f28ea226-cb79-46df-ac0b-fde5d5b93343 --><h2>What are the clinical features and diagnostic criteria for migraine?</h2><!-- end field f28ea226-cb79-46df-ac0b-fde5d5b93343 -->","summary":"","htmlStringContent":"<!-- begin item 2cc3cab8-bf56-41e7-a9bb-273fa16ef47d --><!-- begin field e8ad9387-91ed-4689-9877-987b28a8adbd --><ul><li><strong>Migraine <em>without </em>aura can be diagnosed in a person presenting with at least five attacks fulfilling the following criteria</strong><strong>:</strong><ul><li>Headache lasting 4–72 hours in adults or 2–72 hours in adolescents.</li><li>Headache with at least two of the following characteristics:<ul><li>Unilateral location (more commonly bilateral in children).</li><li>Pulsating quality — may be described as ‘throbbing’ or ‘banging' in young people.</li><li>Moderate or severe pain intensity.</li><li>Aggravation by, or causing avoidance of, routine activities of daily life (for example walking or climbing stairs).</li></ul></li><li>Headache with associated symptoms including at least one of:<ul><li>Nausea and/or vomiting.</li><li>Photophobia (sensitivity to light) and phonophobia (sensitivity to sound).</li></ul></li><li>Headache must not be better accounted for by another diagnosis.</li></ul></li><li><strong>Migraine <em>with </em>aura can be diagnosed in a person presenting with at least two attacks fulfilling the following criteria:</strong><ul><li>One or more <em>typical</em> fully reversible aura symptoms including:<ul><li>Visual symptoms such as zigzag lines and/or scotoma — visual aura is the most common type of aura.</li><li>Sensory symptoms such as unilateral pins and needles or numbness.</li><li>Speech and/or language symptoms such as dysphasia.</li></ul></li><li>At least three of the following:<ul><li>At least one aura symptom spreads gradually over at least 5 minutes.</li><li>Two or more aura symptoms occur in succession.</li><li>Each individual aura symptom lasts 5-60 minutes.</li><li>At least one aura symptom is unilateral.</li><li>At least one aura symptom is positive.</li><li>The aura is accompanied, or followed within 60 minutes, by headache.</li></ul></li><li>Headache must not be better accounted for by another diagnosis.</li></ul></li><li><strong>Atypical aura</strong><ul><li>Motor, brainstem or retinal aura symptoms are <em>not</em> typical.</li><li>Depending on the clinical situation admission or urgent specialist advice is indicated for people presenting with atypical neurological symptoms of aura such as:<ul><li>Motor weakness.</li><li>Double vision.</li><li>Visual symptoms affecting only one eye.</li><li>Poor balance.</li><li>Decreased level of consciousness.</li></ul></li></ul></li><li><strong>Aura without headache</strong><ul><li>Migraine attacks in which typical aura is not followed by headache can occur. The absence of headache makes exclusion of other causes (such as transient ischaemic attack) difficult.<ul><li>Investigation is often indicated especially if aura without migraine headache occurs for the first time after 40 years of age and symptoms are exclusively negative (for example hemianopia) or if aura is prolonged or very short.</li></ul></li></ul></li><li><strong>Prodromal and postdromal symptoms</strong><ul><li>Prodromal symptoms (such as fatigue, poor concentration, neck stiffness, and yawning) may occur hours or 1–2 days before onset of other symptoms of migraine.</li><li>Postdromal symptoms (such as fatigue and elated or depressed mood) may occur after resolution of the headache and last up to 48 hours.</li></ul></li><li><strong>Episodic migraine can be diagnosed in people presenting with:</strong><ul><li>Migraine occurring on less than 15 days per month.</li></ul></li><li><strong>Chronic migraine can be diagnosed in people presenting with:</strong><ul><li>Headache occurring on at least 15 days per month (with features of migraine headache on at least 8 days per month) for more than 3 months.</li><li>Headache must not be better accounted for by another diagnosis.</li></ul></li><li><strong>Menstrual-related migraine should be suspected in:</strong><ul><li>Women/girls with migraine occurring predominantly between 2 days before and 3 days after the start of menstruation for at least 2 out of 3 consecutive menstrual cycles.</li></ul></li></ul><!-- end field e8ad9387-91ed-4689-9877-987b28a8adbd --><!-- end item 2cc3cab8-bf56-41e7-a9bb-273fa16ef47d -->","topic":{"id":"b2a19577-fc3a-5b75-948b-7c86424dba8f","topicId":"8d5c9fe8-c317-4160-9aa5-50f3a0456472","topicName":"Migraine","slug":"migraine","lastRevised":"Last revised in October 2020","chapters":[{"id":"f5de766d-b899-5cb2-978f-7194e0cbeaf4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"57045461-bc73-53e8-9968-49ab778a037a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"32406f3a-91ba-5801-9ef0-87ad7d9b3133","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"52e6d993-e2b2-59c3-920f-27f34a7ec2eb","slug":"changes","fullItemName":"Changes"},{"id":"9560b149-423e-5bf5-8239-ae3f4bc97616","slug":"update","fullItemName":"Update"}]},{"id":"f6c897d2-fd52-5c54-a91b-1b366dced50e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"058608e6-7b11-54ed-9d12-69b94ea020cf","slug":"goals","fullItemName":"Goals"},{"id":"95d8aa4b-0bce-5da9-b56a-a612d637a001","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f9b5443b-1c38-5f3c-be42-3e7fffa429e3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5644cb5-763c-596c-8c47-919fec89ce47","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"92308844-16f7-5eeb-9c0a-ad97a07896ec","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b97a29bb-bac7-5bc8-907c-210d887086f2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"986db6f6-7568-5e6e-8095-5ce116d22307","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b6d1719e-8f6a-509b-90d2-7d1f38e19b05","slug":"definition","fullItemName":"Definition"},{"id":"e35d9975-5859-5454-9539-fab1a8ca6a43","slug":"causes","fullItemName":"Causes"},{"id":"3d8350c0-8bc5-5793-a577-411bc703d36f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"eea7fb2e-ce45-5fa7-9ff5-5399f8305dd7","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ad3ec7a1-a418-5232-b554-b202784e3f46","slug":"complications","fullItemName":"Complications"}]},{"id":"23b2a2ec-5694-51eb-97af-5e80f8d0b792","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"86e96919-af81-53dc-805a-36533fa27637","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"1b00b35a-f7c5-5dc3-bd7d-6e72a973af14","slug":"assessment","fullItemName":"Assessment"},{"id":"33c2a435-70da-50e9-b336-2d81b68f99c9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1ece6bbf-1986-5392-be1d-427e9603f26a","fullItemName":"Management","slug":"management","subChapters":[{"id":"eb14162e-c87a-5ca7-8eda-4acb5c336298","slug":"adults","fullItemName":"Scenario: Adults"},{"id":"3bced75d-3a79-536f-976d-875a40bf1a8d","slug":"young-people-aged-12-17-years","fullItemName":"Scenario: Young people aged 12-17 years"},{"id":"604f5c24-3920-5626-893b-9c27575decc6","slug":"pregnant-or-breastfeeding-women","fullItemName":"Scenario: Pregnant or breastfeeding women"}]},{"id":"8e2844f3-6843-5776-a5a1-59b0cabc5b93","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d1661673-77b9-587b-94ce-e5b6ff9de8c5","slug":"drugs-for-acute-migraine","fullItemName":"Drugs for acute migraine"},{"id":"b69cd3a2-8118-552d-ba35-c7db1a498617","slug":"drugs-for-the-prevention-of-migraine","fullItemName":"Drugs for the prevention of migraine"}]},{"id":"daf55050-4154-5b6d-b8ab-0f86775d1038","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0fbeb3e2-26df-5d63-a045-8af31aed07ef","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"88a22f7c-7eb4-5b57-a406-ab204723d6c0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"596ed3f2-0ac4-5fd9-9046-b304311543ee","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c4597510-7ec3-5f98-b5a5-3ef55cd51b5e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"79a12dcb-038c-5fd4-a311-648c3ee61102","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41030681-d726-58c4-b509-29748e404597","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9a8a7e48-db76-50eb-a585-96fe1b4a5977","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"23b2a2ec-5694-51eb-97af-5e80f8d0b792","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"212d38be-63a2-5f78-b854-4e637b3feb1a","slug":"basis-for-recommendation-39b","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 557f2e1e-62ac-454e-ba7a-44422a9e04ef --><h3>Basis for recommendation</h3><!-- end field 557f2e1e-62ac-454e-ba7a-44422a9e04ef -->","summary":null,"htmlStringContent":"<!-- begin item 39b18b90-2bf6-4aad-a4d5-7cf5698b1560 --><!-- begin field 5bf6f9fd-1816-445b-afc9-6a79cd287790 --><p>The information on clinical features and diagnostic criteria for migraine is based on clinical guidance from the National Institute for Health and Care Excellence (NICE) <em>Headaches in over 12s: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">NICE, 2012 (updated 2015)</a>], the Headache Classification Committee of the International Headache Society (IHS) <em>The International Classification of Headache Disorders, 3rd edition</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>] and Sottish Intercollegiate Guidelines Network (SIGN) <em>Pharmacological management of migraine</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">SIGN, 2018</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Schwedt, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Becker, 2015</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Dodick, 2018</a>].</p><h4>Migraine characteristics</h4><ul><li>Migraine headache is reported to be unilateral in 60% of cases, throbbing in 50%, and aggravated by physical activity in 90%. Headache can change sides during or between attacks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Dodick, 2018</a>].</li><li>In children and adolescents (aged under 18 years) bilateral headache occurs more often than in adults and is usually frontotemporal. Occipital headache in children is rare and alternative underlying causes should be considered [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li></ul><h4>Exclude other causes</h4><ul><li>The International Classification of Headache Disorders (ICHD) diagnostic criteria specifies that ‘headache must not be better accounted for by another diagnosis’ – a thorough assessment must be carried out in all cases and the differential diagnoses considered [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li></ul><h4>Aura</h4><ul><li>Migraine with typical aura can include:<ul><li>Visual and/or sensory and/or speech/language symptoms — visual aura is the most common type of aura and occurs in over 90% of people who have migraine with aura [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li><li>Sensory aura often presents with unilateral pins and needles and or numbness which gradually moves away from the point of origin on the body, face and/or tongue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li></ul></li><li>The ICHD diagnostic criteria for migraine with typical aura <strong><em>does not</em></strong> include motor, brainstem or retinal symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>]:<ul><li>Motor symptoms are often longer lasting (up to 72 hours) than typical aura – other causes of symptoms (such as stroke) must be considered [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li><li>NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">NICE, 2012 (updated 2015)</a>]  and Institute of Health Economics Alberta [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Becker, 2015</a>] recommend that referral/further investigations are considered in people presenting with atypical aura symptoms.</li></ul></li><li>The information on aura without migraine headache is from the ICHD diagnostic criteria for <em>Typical aura without headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li></ul><h4>Chronic migraine</h4><ul><li>Medication overuse occurs frequently with chronic migraine (up to 50% of patients with chronic migraine revert to episodic migraine after drug withdrawal) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">ICHD, 2018</a>].</li><li>Medication overuse headache can result from, and is perpetuated by, overuse of acute or symptomatic headache medications such as triptans, opioids, nonsteroidal anti-inflammatories (NSAIDs) and paracetamol. Simple analgesics (alone or in combination with caffeine) are the most frequently overused drugs followed by triptans [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Katsarava, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Da Silva, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Kristoffersen, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">Green, 2016</a>].</li></ul><h4>Menstrual-related migraine</h4><ul><li>Diagnostic criteria for menstrual-related migraine is from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/migraine/references/\">NICE, 2012 (updated 2015)</a>].</li></ul><!-- end field 5bf6f9fd-1816-445b-afc9-6a79cd287790 --><!-- end item 39b18b90-2bf6-4aad-a4d5-7cf5698b1560 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}